These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disappearance of uremia due to heroin-associated nephropathy. Friedman EA; Tao TK Am J Kidney Dis; 1995 May; 25(5):689-93. PubMed ID: 7747721 [TBL] [Abstract][Full Text] [Related]
5. End-stage renal disease in US minority groups. Feldman HI; Klag MJ; Chiapella AP; Whelton PK Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925 [TBL] [Abstract][Full Text] [Related]
6. Race, socioeconomic status, and the development of end-stage renal disease. Byrne C; Nedelman J; Luke RG Am J Kidney Dis; 1994 Jan; 23(1):16-22. PubMed ID: 8285192 [TBL] [Abstract][Full Text] [Related]
7. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure. Lopes AA Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535 [TBL] [Abstract][Full Text] [Related]
8. Racial differences in the causes of end-stage renal failure in Natal. Seedat YK; Naicker S; Rawat R; Parsoo I S Afr Med J; 1984 Jun; 65(24):956-8. PubMed ID: 6729642 [TBL] [Abstract][Full Text] [Related]
9. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension. Lopes AA; Hornbuckle K; James SA; Port FK Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Perneger TV; Whelton PK; Klag MJ; Rossiter KA Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960 [TBL] [Abstract][Full Text] [Related]
11. Revisiting racial differences in ESRD due to ADPKD in the United States. Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782 [TBL] [Abstract][Full Text] [Related]
12. End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment. Weller JM; Wu SC; Ferguson CW; Hawthorne VM Am J Nephrol; 1985; 5(2):84-95. PubMed ID: 3887922 [TBL] [Abstract][Full Text] [Related]
13. Report from the Caribbean renal registry, 2006. Soyibo AK; Barton EN West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742 [TBL] [Abstract][Full Text] [Related]
14. HLA associations in heroin-associated nephropathy. Haskell LP; Glicklich D; Senitzer D Am J Kidney Dis; 1988 Jul; 12(1):45-50. PubMed ID: 3389354 [TBL] [Abstract][Full Text] [Related]
15. An update of the End-Stage Renal Disease Program at Howard University Hospital. Cruz IA; Hosten AO Transplant Proc; 1989 Dec; 21(6):3892-4. PubMed ID: 2609398 [TBL] [Abstract][Full Text] [Related]
16. Recreational drug use: a neglected risk factor for end-stage renal disease. Perneger TV; Klag MJ; Whelton PK Am J Kidney Dis; 2001 Jul; 38(1):49-56. PubMed ID: 11431181 [TBL] [Abstract][Full Text] [Related]
17. Racial factors in the incidence and causation of end-stage renal disease (ESRD). Easterling RE Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346 [TBL] [Abstract][Full Text] [Related]
18. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Li S; McAlpine DD; Liu J; Li S; Collins AJ Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534 [TBL] [Abstract][Full Text] [Related]